Alx Oncology Holdings (ALXO) Shares Issued (2019 - 2025)

Alx Oncology Holdings (ALXO) has 7 years of Shares Issued data on file, last reported at $12.9 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Issued rose 22.31% year-over-year to $12.9 million; the trailing twelve-month figure through Dec 2025 stood at $12.9 million (up 22.31% YoY), and the FY2025 full-year result was $12.9 million, up 22.31% from the prior year.
• Shares Issued improved to $12.9 million in Q4 2025, from $10.5 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $12.9 million in Q4 2025 to a low of $5.1 million in Q4 2021.
• A 5-year average of $8.7 million and a median of $9.0 million in 2023 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued gained 5.59% in 2021 and soared 44.99% in 2023, its largest moves.
• Tracing ALXO's Shares Issued over 5 years: stood at $5.1 million in 2021, then increased by 20.83% to $6.2 million in 2022, then surged by 44.99% to $9.0 million in 2023, then rose by 17.19% to $10.5 million in 2024, then increased by 22.31% to $12.9 million in 2025.
• Business Quant data shows ALXO's Shares Issued at $12.9 million in Q4 2025, $10.5 million in Q4 2024, and $9.0 million in Q4 2023.